The test is designed to detect biomarkers for early diagnosis of pancreatic cancer, improving patients’ prognosis.
The study classified two diagnostic panels based on microRNAs in whole blood.
More Articles on Gastroenterology:
Looking Beyond the Scope: Integrated Care & Women’s Health in Gastroenterology
Cost-Effective Question: FMT vs. Antibiotics
6 Statistics on Colorectal Cancer Diagnosis & Mortality
